A Phase 3 Multicenter, Prospective, Open-Label Efficacy and Safety Study of Immune Globulin (Human) 10% Caprylate/Chromatography Purified in Patients with Myasthenia Gravis Exacerbations

Background: Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular transmission. Exacerbations may involve increasing bulbar weakness and/or sudden respiratory failure, both of which can be critically disabling. Management of MG exacerbations includes plasma exchange and intravenou...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European neurology 2019-11, Vol.81 (5-6), p.223-230
Hauptverfasser:	Karelis, Guntis, Balasa, Rodica, De Bleecker, Jan L., Stuchevskaya, Tima, Villa, Andres, Van Damme, Philip, Lagrange, Emmeline, Heckmann, Jeannine M., Nicolle, Michael, Vilciu, Crisandra, Bril, Vera, Mondou, Elsa, Griffin, Rhonda, Chen, Junliang, Henriquez, Waleska, Garcia, Beatriz, Camprubi, Sandra, Ayguasanosa, Jaume
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical Neurology: Research Article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!